Vaidas Dirse
Overview
Explore the profile of Vaidas Dirse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hinz F, Friedel D, Korshunov A, Ippen F, Bogumil H, Banan R, et al.
Acta Neuropathol
. 2025 Feb;
149(1):12.
PMID: 39899075
IDH-mutant astrocytomas are diffuse gliomas that are defined by characteristic mutations in IDH1 or IDH2 and do not have complete 1p/19q co-deletion. The established grading criteria include histological features of...
2.
Kalinauskiene R, Brazdziunaite D, Burokiene N, Dirse V, Morkuniene A, Utkus A, et al.
Medicina (Kaunas)
. 2023 Jun;
59(6).
PMID: 37374360
Only nine patients with interstitial de novo 8q22.2q22.3 microdeletions have been reported to date. The objective of this report is to present clinical features of a new patient with an...
3.
Noren-Nystrom U, Andersen M, Barbany G, Dirse V, Eilert-Olsen M, Engvall M, et al.
Hemasphere
. 2023 May;
7(5):e883.
PMID: 37153872
No abstract available.
4.
Stukaite-Ruibiene E, Norvilas R, Dirse V, Stankeviciene S, Vaitkeviciene G
Pathol Oncol Res
. 2022 Sep;
28:1610570.
PMID: 36172171
Acute lymphoblastic leukemia (ALL) with recurrent genetic lesions, affecting a series of kinase genes, is associated with unfavorable prognosis, however, it could benefit from treatment with tyrosine kinase inhibitors (TKI)....
5.
Radzevicius M, Dirse V, Klimiene I, Matuzeviciene R, Kucinskiene Z, Peceliunas V
Diagnostics (Basel)
. 2022 Sep;
12(9).
PMID: 36140450
(1) Background: At diagnosis, multiplemyeloma risk estimation includes disease burden, end-organ damage, and biomarkers, with increasing emphasis on genetic abnormalities. Multicolor flow cytometry (MFC) is not always considered in risk...
6.
Norvilas R, Batiuskaite R, Dirse V, Semaskeviciene R, Gineikiene E, Stoskus M, et al.
Leuk Res
. 2022 Mar;
116:106825.
PMID: 35339799
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically diverse disease characterized by a heterogeneous profile of genetic lesions. Recent transcriptome studies identified a number of new T-ALL-related gene fusions....
7.
Norvilas R, Dirse V, Semaskeviciene R, Mickeviciute O, Gineikiene E, Stoskus M, et al.
BMC Cancer
. 2021 Mar;
21(1):326.
PMID: 33781217
Background: ABL-class and JAK-STAT signaling pathway activating alterations have been associated with both a poor post-induction minimal residual disease (MRD) response and an inferior outcome in B-cell acute lymphoblastic leukemia...
8.
Zucenka A, Pileckyte R, Trociukas I, Peceliunas V, Vaitekenaite V, Maneikis K, et al.
Eur J Haematol
. 2020 Sep;
106(1):105-113.
PMID: 32997830
Objectives And Methods: We conducted a retrospective analysis to evaluate the outcomes of 28 heavily pretreated (median 3 (2-6) treatment lines, sixteen (57%) allotransplanted) relapsed/refractory acute myeloid leukemia patients who...
9.
Dirse V, Norvilas R, Gineikiene E, Matuzeviciene R, Griskevicius L, Preiksaitiene E
Leuk Lymphoma
. 2017 Aug;
59(4):1022-1024.
PMID: 28776427
No abstract available.
10.
Aleksiuniene B, Matuleviciute R, Matuleviciene A, Burnyte B, Krasovskaja N, Ambrozaityte L, et al.
Medicine (Baltimore)
. 2017 Apr;
96(16):e6521.
PMID: 28422838
Rationale: Chromosomal rearrangements are the major cause of multiple congenital abnormalities and intellectual disability. Patient Concerns And Diagnosis: We report 2 first cousins with unbalanced chromosomal aberrations of chromosomes 1...